In addition, our results also point out for the first time a potential association between DHRs to two or more NSAIDs or other COXi and a higher MC burden, supporting a role for clonal MC (and potentially also other immune cells) in mastocytosis in favoring hypersensitivity reactions to these drugs. This evidence concerns the gene MT-CO1 and mastocytosis.